The Business Research Company's Guillain-Barre Syndrome Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 Updated 2025 Market Reports Released: Trends, Forecasts to ...

SAN DIEGO -- A single dose of investigational tanruprubart resulted in rapid, sustained improvement in disability compared with placebo in patients with Guillain-Barré syndrome (GBS), a phase III ...

SHREVEPORT, La. - In 2011, Shane Sumlin's life changed overnight after being diagnosed with a rare neurological disorder ...

Guillain-Barré Syndrome: The Frightening Illness Linked to Your Favourite Foods.(Photo by RDNE Stock) She pointed out, “A plant-based diet of whole foods naturally enhances immunity by ...

We present a case of Guillain-Barré syndrome in a child who received hepatitis A vaccine 5 days before onset of the clinical symptoms. In our patient, the association of Guillain-Barré syndrome ...

Max had his nine-month checkup, and he's recovering well from Guillain-Barré syndrome. Chelsea says Max is 80% recovered. Guillain-Barré syndrome is a rare neurological disorder in which a ...

Swedish biotechnology firm Hansa Biopharma has announced that its investigational drug imlifidase improved motor function in patients with Guillain-Barré Syndrome (GBS) in a Phase II study.

Background Guillain-Barre syndrome (GBS) is characterized by acute onset and progressive course, and is usually associated with a good prognosis. However, there are forms of poor prognosis ...

Finally, four months after her symptoms began, Abraham was diagnosed with a form of Guillain-Barré syndrome, a rare neurological disorder where the fibers around the nerves deteriorate and cause ...

The toddler was diagnosed with Guillain-Barré syndrome after he was hospitalized in the summer Chelsea Freeman/ Instagram Chelsea and Freddie Freeman's son is showing encouraging progress ...

This is the 11th year that Little Eric’s Foundation participated, as an organization, in Cycle for Survival in New York City. Cycle for Survival is a nationwide movement to beat rare cancers ...